The proposed bill establishes the Task Force on Diabetes Management within the Florida Department of Health, which will assess the need for a referral program for individuals diagnosed with diabetes to access treatment at federally qualified health centers, regardless of their health coverage status. The task force is tasked with developing referral criteria and must submit a report to the Governor and Legislature by May 1, 2026. Additionally, the bill allows the State Surgeon General to reestablish the task force if necessary and mandates the establishment of a program by January 1, 2027, unless certain conditions prevent its implementation.

Furthermore, the bill amends existing laws to enable pharmacists to prescribe and dispense a 30-day supply of insulin and diabetes-related devices under specific circumstances, ensuring that patients are charged no more than their insurance copayment or the usual cost if uninsured. It also requires health insurance policies to cover laboratory testing and screening for diabetes without imposing certain cost-sharing requirements. The bill introduces definitions for various diabetes-related terms and mandates that health insurance policies cover laboratory and diagnostic testing for diabetes, with cost-sharing limits set at $35 for a 30-day supply of insulin, noninsulin, or glucagon drugs, and $100 for diabetes devices. Additionally, health maintenance contracts must provide similar coverage, and dispensers are required to report all relevant drugs and devices dispensed. The act is set to take effect on July 1, 2025.